NCT03417648

Brief Summary

The purpose of the study is to assess whether, in individuals with rheumatoid arthritis, a low-fat, vegan diet improves pain and other subjective symptoms more effectively than a control supplement or a placebo. The principal measure is pain as measured by Visual Analog Scale (VAS) and disease activity as measured by number of painful swollen and tender joints, respectively. The study duration is 36 weeks. This study tests that a low fat, plant-based (vegan) diet free of foods commonly identified as triggers improves mood, using the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R), and the Beck Depression Inventory II (BDI-II).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable rheumatoid-arthritis

Timeline
Completed

Started Mar 2018

Shorter than P25 for not_applicable rheumatoid-arthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 25, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 31, 2018

Completed
1 month until next milestone

Study Start

First participant enrolled

March 8, 2018

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 14, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 14, 2018

Completed
Last Updated

March 4, 2019

Status Verified

March 1, 2019

Enrollment Period

9 months

First QC Date

January 25, 2018

Last Update Submit

March 1, 2019

Conditions

Keywords

Rheumatoid Arthritis, Diet, Fat-Restricted, Diet, Vegetarian

Outcome Measures

Primary Outcomes (3)

  • Pain Score

    will be measured by visual analog scale from 0%, indicating no pain, to 100%, indicating pain as bad as it could possibly be

    Change in pain score from Baseline at 4 months

  • Disease Activity score

    measured by number of painful, swollen and tender joints

    Change in disease activity score from Baseline at 4 months

  • Improvement in mood

    measured by the Beck Depression Inventory II (BDI-II).

    Change in mood from Baseline at 4 months

Secondary Outcomes (1)

  • Quality of Life

    Change in quality of life from Baseline at 4 months

Study Arms (2)

Plant-based diet

EXPERIMENTAL

The diet group will be asked to follow a low-fat, vegan diet for 16 weeks

Other: Plant-based diet

Supplement

PLACEBO COMPARATOR

The supplement group will follow an unrestricted diet, but will be given a pill containing a small, clinically insignificant amount of omega- 3 oils and vitamin E, which will serve as a placebo.

Other: Supplement

Interventions

Weekly instructions will be given to the participants in the intervention group about following vegan diet.

Plant-based diet

unrestricted diet with clinically insignificant amount of omega- 3 oils and vitamin E

Also known as: Vitamin E
Supplement

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A diagnosis of rheumatoid arthritis based on 2010 ACR / EULAR Rheumatoid Arthritis Classification Criteria. Classification as "definite RA" is based on:
  • the confirmed presence of synovitis in at least 1 joint
  • absence of an alternative diagnosis that better explains the synovitis
  • and achievement of a total score of 6 or greater (of a possible 10): 24 Joint involvement, designating the metacarpophalangeal joints, proximal interphalangeal joints, the interphalangeal joint of the thumb, second through third metatarsophalangeal joint and wrist as small joints, and elbows, hip joints and knees as large joints:
  • Involvement of 1 large joint gives 0 points
  • Involvement of 2-10 large joints gives 1 point
  • Involvement of 1-3 small joints (with or without involvement of large joints) gives 2 points
  • Involvement of 4-10 small joints (with or without involvement of large joints) gives 3 points
  • Involvement of more than 10 joints (with involvement of at least 1 small joint) gives 5 points
  • Serological parameters - including the rheumatoid factor as well as anti-citrullinated protein antibody (ACPA):
  • Negative RF and negative ACPA gives 0 points
  • Low-positive RF or low-positive ACPA gives 2 points
  • High-positive RF or high-positive ACPA gives 3 points Acute phase reactants: 1 point for elevated erythrocyte sedimentation rate (ESR) or elevated C-reactive protein (CRP) value Duration of arthritis: 1 point for symptoms lasting six weeks or longer
  • Continuing or recurring pain (i.e., joint pain daily, unless on pain medication).
  • Age at least 18 years
  • +3 more criteria

You may not qualify if:

  • \< 18 years of age
  • Alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
  • Pregnancy
  • Unstable medical or psychiatric illness
  • Likely to be disruptive in group sessions (as determined by research staff)
  • Already following a low-fat, vegan diet
  • Lack of English fluency
  • Inability to maintain current medication regimen
  • Inability or unwillingness to participate in all components of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physicians Committee for Responsible Medicine

Washington D.C., District of Columbia, 20016, United States

Location

Related Publications (1)

  • Barnard ND, Levin S, Crosby L, Flores R, Holubkov R, Kahleova H. A Randomized, Crossover Trial of a Nutritional Intervention for Rheumatoid Arthritis. Am J Lifestyle Med. 2022 Apr 3;19(2):266-275. doi: 10.1177/15598276221081819. eCollection 2025 Feb.

MeSH Terms

Conditions

Arthritis, Rheumatoid

Interventions

Diet, Plant-BasedDietary SupplementsVitamin E

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological PhenomenaFoodFood and BeveragesBenzopyransPyransHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-Ring

Study Officials

  • Neal D Barnard

    Physicians Committee for Responsible Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2018

First Posted

January 31, 2018

Study Start

March 8, 2018

Primary Completion

December 14, 2018

Study Completion

December 14, 2018

Last Updated

March 4, 2019

Record last verified: 2019-03

Locations